International Stem Cell Corporation

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, NONOF has a market cap of 301.9B. Regarding current trading prices, ISCO is priced at $0.17, while NONOF trades at $68.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas NONOF's P/E ratio is 19.05. In terms of profitability, ISCO's ROE is +0.32%, compared to NONOF's ROE of +0.81%. Regarding short-term risk, ISCO is more volatile compared to NONOF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, CSLLY has a market cap of 154B. Regarding current trading prices, ISCO is priced at $0.17, while CSLLY trades at $79.49.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas CSLLY's P/E ratio is 29.22. In terms of profitability, ISCO's ROE is +0.32%, compared to CSLLY's ROE of +0.15%. Regarding short-term risk, ISCO is more volatile compared to CSLLY. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, CMXHF has a market cap of 74.9B. Regarding current trading prices, ISCO is priced at $0.17, while CMXHF trades at $154.72.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas CMXHF's P/E ratio is 28.39. In terms of profitability, ISCO's ROE is +0.32%, compared to CMXHF's ROE of +0.15%. Regarding short-term risk, ISCO is more volatile compared to CMXHF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, ARGNF has a market cap of 34.3B. Regarding current trading prices, ISCO is priced at $0.17, while ARGNF trades at $562.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas ARGNF's P/E ratio is 34.25. In terms of profitability, ISCO's ROE is +0.32%, compared to ARGNF's ROE of +0.16%. Regarding short-term risk, ISCO is more volatile compared to ARGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, UCBJF has a market cap of 33.4B. Regarding current trading prices, ISCO is priced at $0.17, while UCBJF trades at $175.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas UCBJF's P/E ratio is 28.17. In terms of profitability, ISCO's ROE is +0.32%, compared to UCBJF's ROE of +0.03%. Regarding short-term risk, ISCO is more volatile compared to UCBJF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, UCBJY has a market cap of 33.4B. Regarding current trading prices, ISCO is priced at $0.17, while UCBJY trades at $87.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas UCBJY's P/E ratio is 28.13. In terms of profitability, ISCO's ROE is +0.32%, compared to UCBJY's ROE of +0.03%. Regarding short-term risk, ISCO is more volatile compared to UCBJY. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, ODTC has a market cap of 24.1B. Regarding current trading prices, ISCO is priced at $0.17, while ODTC trades at $22,005.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas ODTC's P/E ratio is -0.08. In terms of profitability, ISCO's ROE is +0.32%, compared to ODTC's ROE of +0.07%. Regarding short-term risk, ISCO is more volatile compared to ODTC. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, GNMSF has a market cap of 12.9B. Regarding current trading prices, ISCO is priced at $0.17, while GNMSF trades at $209.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas GNMSF's P/E ratio is 12.31. In terms of profitability, ISCO's ROE is +0.32%, compared to GNMSF's ROE of +0.26%. Regarding short-term risk, ISCO is more volatile compared to GNMSF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, IVBXF has a market cap of 12.5B. Regarding current trading prices, ISCO is priced at $0.17, while IVBXF trades at $7.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas IVBXF's P/E ratio is -755.00. In terms of profitability, ISCO's ROE is +0.32%, compared to IVBXF's ROE of -0.01%. Regarding short-term risk, ISCO is more volatile compared to IVBXF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, WXIBF has a market cap of 12.2B. Regarding current trading prices, ISCO is priced at $0.17, while WXIBF trades at $3.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas WXIBF's P/E ratio is 27.27. In terms of profitability, ISCO's ROE is +0.32%, compared to WXIBF's ROE of +0.06%. Regarding short-term risk, ISCO is more volatile compared to WXIBF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, WXXWY has a market cap of 11.9B. Regarding current trading prices, ISCO is priced at $0.17, while WXXWY trades at $5.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas WXXWY's P/E ratio is 26.64. In terms of profitability, ISCO's ROE is +0.32%, compared to WXXWY's ROE of +0.06%. Regarding short-term risk, ISCO is more volatile compared to WXXWY. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, SBMFF has a market cap of 9.7B. Regarding current trading prices, ISCO is priced at $0.17, while SBMFF trades at $0.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas SBMFF's P/E ratio is 54.20. In terms of profitability, ISCO's ROE is +0.32%, compared to SBMFF's ROE of +0.11%. Regarding short-term risk, ISCO is less volatile compared to SBMFF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, SBHMY has a market cap of 8.5B. Regarding current trading prices, ISCO is priced at $0.17, while SBHMY trades at $9.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas SBHMY's P/E ratio is 32.69. In terms of profitability, ISCO's ROE is +0.32%, compared to SBHMY's ROE of +0.11%. Regarding short-term risk, ISCO is more volatile compared to SBHMY. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, TRSBF has a market cap of 6.1B. Regarding current trading prices, ISCO is priced at $0.17, while TRSBF trades at $2.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas TRSBF's P/E ratio is 23.64. In terms of profitability, ISCO's ROE is +0.32%, compared to TRSBF's ROE of +0.11%. Regarding short-term risk, ISCO is more volatile compared to TRSBF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, TLPPF has a market cap of 5.6B. Regarding current trading prices, ISCO is priced at $0.17, while TLPPF trades at $16.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas TLPPF's P/E ratio is 183.80. In terms of profitability, ISCO's ROE is +0.32%, compared to TLPPF's ROE of +0.14%. Regarding short-term risk, ISCO is more volatile compared to TLPPF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, ABCZF has a market cap of 5.1B. Regarding current trading prices, ISCO is priced at $0.17, while ABCZF trades at $22.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas ABCZF's P/E ratio is 2225.00. In terms of profitability, ISCO's ROE is +0.32%, compared to ABCZF's ROE of -0.01%. Regarding short-term risk, ISCO is more volatile compared to ABCZF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, ZLDPF has a market cap of 4.9B. Regarding current trading prices, ISCO is priced at $0.17, while ZLDPF trades at $69.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas ZLDPF's P/E ratio is -26.36. In terms of profitability, ISCO's ROE is +0.32%, compared to ZLDPF's ROE of -0.13%. Regarding short-term risk, ISCO is more volatile compared to ZLDPF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, INCPF has a market cap of 4.9B. Regarding current trading prices, ISCO is priced at $0.17, while INCPF trades at $3.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas INCPF's P/E ratio is -108.67. In terms of profitability, ISCO's ROE is +0.32%, compared to INCPF's ROE of -0.05%. Regarding short-term risk, ISCO is more volatile compared to INCPF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, AKBLF has a market cap of 4.8B. Regarding current trading prices, ISCO is priced at $0.17, while AKBLF trades at $21.35.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas AKBLF's P/E ratio is 33.36. In terms of profitability, ISCO's ROE is +0.32%, compared to AKBLF's ROE of +0.18%. Regarding short-term risk, ISCO is more volatile compared to AKBLF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, LABFF has a market cap of 4.6B. Regarding current trading prices, ISCO is priced at $0.17, while LABFF trades at $90.61.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas LABFF's P/E ratio is 28.95. In terms of profitability, ISCO's ROE is +0.32%, compared to LABFF's ROE of +0.39%. Regarding short-term risk, ISCO is more volatile compared to LABFF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, REGMF has a market cap of 3.4B. Regarding current trading prices, ISCO is priced at $0.17, while REGMF trades at $5.06.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas REGMF's P/E ratio is -13.32. In terms of profitability, ISCO's ROE is +0.32%, compared to REGMF's ROE of -0.48%. Regarding short-term risk, ISCO is more volatile compared to REGMF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, SHJBF has a market cap of 3.4B. Regarding current trading prices, ISCO is priced at $0.17, while SHJBF trades at $1.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas SHJBF's P/E ratio is -10.94. In terms of profitability, ISCO's ROE is +0.32%, compared to SHJBF's ROE of -0.27%. Regarding short-term risk, ISCO is less volatile compared to SHJBF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, CAMRF has a market cap of 3.3B. Regarding current trading prices, ISCO is priced at $0.17, while CAMRF trades at $56.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas CAMRF's P/E ratio is 58.33. In terms of profitability, ISCO's ROE is +0.32%, compared to CAMRF's ROE of +0.14%. Regarding short-term risk, ISCO is less volatile compared to CAMRF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, GNNSF has a market cap of 2.9B. Regarding current trading prices, ISCO is priced at $0.17, while GNNSF trades at $1.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas GNNSF's P/E ratio is -16.94. In terms of profitability, ISCO's ROE is +0.32%, compared to GNNSF's ROE of -0.06%. Regarding short-term risk, ISCO is more volatile compared to GNNSF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, TKBIF has a market cap of 2.8B. Regarding current trading prices, ISCO is priced at $0.17, while TKBIF trades at $23.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas TKBIF's P/E ratio is 18.71. In terms of profitability, ISCO's ROE is +0.32%, compared to TKBIF's ROE of N/A. Regarding short-term risk, ISCO is more volatile compared to TKBIF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, MPSYF has a market cap of 2.8B. Regarding current trading prices, ISCO is priced at $0.17, while MPSYF trades at $73.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas MPSYF's P/E ratio is -12.13. In terms of profitability, ISCO's ROE is +0.32%, compared to MPSYF's ROE of +7.43%. Regarding short-term risk, ISCO is more volatile compared to MPSYF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, ASPHF has a market cap of 2.2B. Regarding current trading prices, ISCO is priced at $0.17, while ASPHF trades at $6.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas ASPHF's P/E ratio is -35.83. In terms of profitability, ISCO's ROE is +0.32%, compared to ASPHF's ROE of -0.70%. Regarding short-term risk, ISCO is more volatile compared to ASPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, BVNKF has a market cap of 2.1B. Regarding current trading prices, ISCO is priced at $0.17, while BVNKF trades at $26.80.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas BVNKF's P/E ratio is 10.47. In terms of profitability, ISCO's ROE is +0.32%, compared to BVNKF's ROE of +0.12%. Regarding short-term risk, ISCO is less volatile compared to BVNKF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, BVNRY has a market cap of 2B. Regarding current trading prices, ISCO is priced at $0.17, while BVNRY trades at $8.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas BVNRY's P/E ratio is 10.23. In terms of profitability, ISCO's ROE is +0.32%, compared to BVNRY's ROE of +0.12%. Regarding short-term risk, ISCO is more volatile compared to BVNRY. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, BTTAY has a market cap of 1.9B. Regarding current trading prices, ISCO is priced at $0.17, while BTTAY trades at $24.23.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas BTTAY's P/E ratio is -67.31. In terms of profitability, ISCO's ROE is +0.32%, compared to BTTAY's ROE of +0.05%. Regarding short-term risk, ISCO is more volatile compared to BTTAY. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, GENSF has a market cap of 1.8B. Regarding current trading prices, ISCO is priced at $0.17, while GENSF trades at $27.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas GENSF's P/E ratio is -348.31. In terms of profitability, ISCO's ROE is +0.32%, compared to GENSF's ROE of +0.01%. Regarding short-term risk, ISCO is more volatile compared to GENSF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, MEOBF has a market cap of 1.8B. Regarding current trading prices, ISCO is priced at $0.17, while MEOBF trades at $1.43.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas MEOBF's P/E ratio is -15.89. In terms of profitability, ISCO's ROE is +0.32%, compared to MEOBF's ROE of -0.15%. Regarding short-term risk, ISCO is more volatile compared to MEOBF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, GLPGF has a market cap of 1.8B. Regarding current trading prices, ISCO is priced at $0.17, while GLPGF trades at $27.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas GLPGF's P/E ratio is -8.87. In terms of profitability, ISCO's ROE is +0.32%, compared to GLPGF's ROE of -0.06%. Regarding short-term risk, ISCO is more volatile compared to GLPGF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, PPTDF has a market cap of 1.7B. Regarding current trading prices, ISCO is priced at $0.17, while PPTDF trades at $13.53.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas PPTDF's P/E ratio is 16.91. In terms of profitability, ISCO's ROE is +0.32%, compared to PPTDF's ROE of +0.26%. Regarding short-term risk, ISCO is less volatile compared to PPTDF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, PHMMF has a market cap of 1.7B. Regarding current trading prices, ISCO is priced at $0.17, while PHMMF trades at $96.20.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas PHMMF's P/E ratio is 75.16. In terms of profitability, ISCO's ROE is +0.32%, compared to PHMMF's ROE of +0.10%. Regarding short-term risk, ISCO is more volatile compared to PHMMF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, ONTTF has a market cap of 1.7B. Regarding current trading prices, ISCO is priced at $0.17, while ONTTF trades at $1.73.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas ONTTF's P/E ratio is -8.24. In terms of profitability, ISCO's ROE is +0.32%, compared to ONTTF's ROE of -0.27%. Regarding short-term risk, ISCO is more volatile compared to ONTTF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, BRCTF has a market cap of 1.7B. Regarding current trading prices, ISCO is priced at $0.17, while BRCTF trades at $18.74.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas BRCTF's P/E ratio is 17.68. In terms of profitability, ISCO's ROE is +0.32%, compared to BRCTF's ROE of -0.19%. Regarding short-term risk, ISCO is more volatile compared to BRCTF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, BIESF has a market cap of 1.6B. Regarding current trading prices, ISCO is priced at $0.17, while BIESF trades at $32.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas BIESF's P/E ratio is -44.44. In terms of profitability, ISCO's ROE is +0.32%, compared to BIESF's ROE of +0.05%. Regarding short-term risk, ISCO is more volatile compared to BIESF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, BRAXF has a market cap of 1.3B. Regarding current trading prices, ISCO is priced at $0.17, while BRAXF trades at $0.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas BRAXF's P/E ratio is -0.03. In terms of profitability, ISCO's ROE is +0.32%, compared to BRAXF's ROE of -2.49%. Regarding short-term risk, ISCO is less volatile compared to BRAXF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, CSBTF has a market cap of 1.2B. Regarding current trading prices, ISCO is priced at $0.17, while CSBTF trades at $30.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas CSBTF's P/E ratio is -250.00. In terms of profitability, ISCO's ROE is +0.32%, compared to CSBTF's ROE of -0.15%. Regarding short-term risk, ISCO is more volatile compared to CSBTF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, NURPF has a market cap of 1B. Regarding current trading prices, ISCO is priced at $0.17, while NURPF trades at $8.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas NURPF's P/E ratio is 11.67. In terms of profitability, ISCO's ROE is +0.32%, compared to NURPF's ROE of +0.49%. Regarding short-term risk, ISCO is more volatile compared to NURPF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, SNBIF has a market cap of 954.4M. Regarding current trading prices, ISCO is priced at $0.17, while SNBIF trades at $6.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas SNBIF's P/E ratio is -22.59. In terms of profitability, ISCO's ROE is +0.32%, compared to SNBIF's ROE of -0.92%. Regarding short-term risk, ISCO is less volatile compared to SNBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, ASCLF has a market cap of 865.8M. Regarding current trading prices, ISCO is priced at $0.17, while ASCLF trades at $0.89.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas ASCLF's P/E ratio is -22.33. In terms of profitability, ISCO's ROE is +0.32%, compared to ASCLF's ROE of -0.09%. Regarding short-term risk, ISCO is more volatile compared to ASCLF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, CSPHF has a market cap of 703M. Regarding current trading prices, ISCO is priced at $0.17, while CSPHF trades at $0.52.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas CSPHF's P/E ratio is -51.80. In terms of profitability, ISCO's ROE is +0.32%, compared to CSPHF's ROE of -0.14%. Regarding short-term risk, ISCO is less volatile compared to CSPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, PHGUF has a market cap of 680.3M. Regarding current trading prices, ISCO is priced at $0.17, while PHGUF trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas PHGUF's P/E ratio is -50.00. In terms of profitability, ISCO's ROE is +0.32%, compared to PHGUF's ROE of -0.06%. Regarding short-term risk, ISCO is more volatile compared to PHGUF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, BPMUF has a market cap of 582.7M. Regarding current trading prices, ISCO is priced at $0.17, while BPMUF trades at $47.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas BPMUF's P/E ratio is 6.73. In terms of profitability, ISCO's ROE is +0.32%, compared to BPMUF's ROE of -0.01%. Regarding short-term risk, ISCO is less volatile compared to BPMUF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, INRLF has a market cap of 552.7M. Regarding current trading prices, ISCO is priced at $0.17, while INRLF trades at $3.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas INRLF's P/E ratio is -5.08. In terms of profitability, ISCO's ROE is +0.32%, compared to INRLF's ROE of -0.43%. Regarding short-term risk, ISCO is more volatile compared to INRLF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, BXPHF has a market cap of 519.6M. Regarding current trading prices, ISCO is priced at $0.17, while BXPHF trades at $0.27.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas BXPHF's P/E ratio is -26.50. In terms of profitability, ISCO's ROE is +0.32%, compared to BXPHF's ROE of -0.18%. Regarding short-term risk, ISCO is less volatile compared to BXPHF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, IVEVF has a market cap of 505.9M. Regarding current trading prices, ISCO is priced at $0.17, while IVEVF trades at $3.64.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas IVEVF's P/E ratio is -1.05. In terms of profitability, ISCO's ROE is +0.32%, compared to IVEVF's ROE of +1.67%. Regarding short-term risk, ISCO is more volatile compared to IVEVF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, CLTEF has a market cap of 504.7M. Regarding current trading prices, ISCO is priced at $0.17, while CLTEF trades at $7.55.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas CLTEF's P/E ratio is -7.06. In terms of profitability, ISCO's ROE is +0.32%, compared to CLTEF's ROE of -0.61%. Regarding short-term risk, ISCO is more volatile compared to CLTEF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, VBIZF has a market cap of 504.2M. Regarding current trading prices, ISCO is priced at $0.17, while VBIZF trades at $0.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas VBIZF's P/E ratio is 24.20. In terms of profitability, ISCO's ROE is +0.32%, compared to VBIZF's ROE of -0.00%. Regarding short-term risk, ISCO is less volatile compared to VBIZF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, SOLTF has a market cap of 497.1M. Regarding current trading prices, ISCO is priced at $0.17, while SOLTF trades at $5.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas SOLTF's P/E ratio is -30.56. In terms of profitability, ISCO's ROE is +0.32%, compared to SOLTF's ROE of -0.07%. Regarding short-term risk, ISCO is more volatile compared to SOLTF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, CKDXF has a market cap of 475.3M. Regarding current trading prices, ISCO is priced at $0.17, while CKDXF trades at $0.44.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas CKDXF's P/E ratio is -1.26. In terms of profitability, ISCO's ROE is +0.32%, compared to CKDXF's ROE of +2.04%. Regarding short-term risk, ISCO is less volatile compared to CKDXF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, AAVXF has a market cap of 457.4M. Regarding current trading prices, ISCO is priced at $0.17, while AAVXF trades at $7.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas AAVXF's P/E ratio is -2.27. In terms of profitability, ISCO's ROE is +0.32%, compared to AAVXF's ROE of -1.10%. Regarding short-term risk, ISCO is more volatile compared to AAVXF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, TBGNF has a market cap of 433.7M. Regarding current trading prices, ISCO is priced at $0.17, while TBGNF trades at $0.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas TBGNF's P/E ratio is -0.25. In terms of profitability, ISCO's ROE is +0.32%, compared to TBGNF's ROE of N/A. Regarding short-term risk, ISCO is more volatile compared to TBGNF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, CYDY has a market cap of 415.3M. Regarding current trading prices, ISCO is priced at $0.17, while CYDY trades at $0.34.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas CYDY's P/E ratio is -16.85. In terms of profitability, ISCO's ROE is +0.32%, compared to CYDY's ROE of +0.07%. Regarding short-term risk, ISCO is less volatile compared to CYDY. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, HBMHF has a market cap of 407.9M. Regarding current trading prices, ISCO is priced at $0.17, while HBMHF trades at $0.48.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas HBMHF's P/E ratio is 16.07. In terms of profitability, ISCO's ROE is +0.32%, compared to HBMHF's ROE of +0.02%. Regarding short-term risk, ISCO is more volatile compared to HBMHF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, PTCHF has a market cap of 403.5M. Regarding current trading prices, ISCO is priced at $0.17, while PTCHF trades at $1.68.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas PTCHF's P/E ratio is 8.00. In terms of profitability, ISCO's ROE is +0.32%, compared to PTCHF's ROE of -0.22%. Regarding short-term risk, ISCO is more volatile compared to PTCHF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, IDRSF has a market cap of 379.1M. Regarding current trading prices, ISCO is priced at $0.17, while IDRSF trades at $1.86.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas IDRSF's P/E ratio is -1.13. In terms of profitability, ISCO's ROE is +0.32%, compared to IDRSF's ROE of +0.24%. Regarding short-term risk, ISCO is less volatile compared to IDRSF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, NWBO has a market cap of 369.9M. Regarding current trading prices, ISCO is priced at $0.17, while NWBO trades at $0.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas NWBO's P/E ratio is -4.28. In terms of profitability, ISCO's ROE is +0.32%, compared to NWBO's ROE of +1.13%. Regarding short-term risk, ISCO is less volatile compared to NWBO. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, CLVLF has a market cap of 348.4M. Regarding current trading prices, ISCO is priced at $0.17, while CLVLF trades at $6.95.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas CLVLF's P/E ratio is 14.18. In terms of profitability, ISCO's ROE is +0.32%, compared to CLVLF's ROE of +0.19%. Regarding short-term risk, ISCO is more volatile compared to CLVLF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, CLVLY has a market cap of 340.3M. Regarding current trading prices, ISCO is priced at $0.17, while CLVLY trades at $6.79.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas CLVLY's P/E ratio is 13.58. In terms of profitability, ISCO's ROE is +0.32%, compared to CLVLY's ROE of +0.19%. Regarding short-term risk, ISCO is more volatile compared to CLVLY. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, BOVNF has a market cap of 309.3M. Regarding current trading prices, ISCO is priced at $0.17, while BOVNF trades at $4.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas BOVNF's P/E ratio is -8.55. In terms of profitability, ISCO's ROE is +0.32%, compared to BOVNF's ROE of -0.50%. Regarding short-term risk, ISCO is more volatile compared to BOVNF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, PRRUF has a market cap of 306.7M. Regarding current trading prices, ISCO is priced at $0.17, while PRRUF trades at $0.21.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas PRRUF's P/E ratio is -10.50. In terms of profitability, ISCO's ROE is +0.32%, compared to PRRUF's ROE of -0.28%. Regarding short-term risk, ISCO is more volatile compared to PRRUF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, PBBIF has a market cap of 286.9M. Regarding current trading prices, ISCO is priced at $0.17, while PBBIF trades at $24.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas PBBIF's P/E ratio is 266.67. In terms of profitability, ISCO's ROE is +0.32%, compared to PBBIF's ROE of +0.01%. Regarding short-term risk, ISCO is less volatile compared to PBBIF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, NGENF has a market cap of 278.3M. Regarding current trading prices, ISCO is priced at $0.17, while NGENF trades at $3.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas NGENF's P/E ratio is -14.33. In terms of profitability, ISCO's ROE is +0.32%, compared to NGENF's ROE of -2.23%. Regarding short-term risk, ISCO is less volatile compared to NGENF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, ORYZF has a market cap of 234.9M. Regarding current trading prices, ISCO is priced at $0.17, while ORYZF trades at $3.03.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas ORYZF's P/E ratio is -43.29. In terms of profitability, ISCO's ROE is +0.32%, compared to ORYZF's ROE of -0.05%. Regarding short-term risk, ISCO is more volatile compared to ORYZF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, NWPHF has a market cap of 231.2M. Regarding current trading prices, ISCO is priced at $0.17, while NWPHF trades at $12.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas NWPHF's P/E ratio is N/A. In terms of profitability, ISCO's ROE is +0.32%, compared to NWPHF's ROE of N/A. Regarding short-term risk, ISCO is more volatile compared to NWPHF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, MDCLF has a market cap of 230.7M. Regarding current trading prices, ISCO is priced at $0.17, while MDCLF trades at $6.98.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas MDCLF's P/E ratio is -5.21. In terms of profitability, ISCO's ROE is +0.32%, compared to MDCLF's ROE of +0.60%. Regarding short-term risk, ISCO is more volatile compared to MDCLF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, HLOSF has a market cap of 228.3M. Regarding current trading prices, ISCO is priced at $0.17, while HLOSF trades at $2.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas HLOSF's P/E ratio is -7.03. In terms of profitability, ISCO's ROE is +0.32%, compared to HLOSF's ROE of -1.30%. Regarding short-term risk, ISCO is less volatile compared to HLOSF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, RAONF has a market cap of 212M. Regarding current trading prices, ISCO is priced at $0.17, while RAONF trades at $1.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas RAONF's P/E ratio is -20.33. In terms of profitability, ISCO's ROE is +0.32%, compared to RAONF's ROE of -0.71%. Regarding short-term risk, ISCO is less volatile compared to RAONF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, FPHAF has a market cap of 209.5M. Regarding current trading prices, ISCO is priced at $0.17, while FPHAF trades at $3.30.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas FPHAF's P/E ratio is -7.50. In terms of profitability, ISCO's ROE is +0.32%, compared to FPHAF's ROE of N/A. Regarding short-term risk, ISCO is more volatile compared to FPHAF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, VSBC has a market cap of 207M. Regarding current trading prices, ISCO is priced at $0.17, while VSBC trades at $1.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas VSBC's P/E ratio is N/A. In terms of profitability, ISCO's ROE is +0.32%, compared to VSBC's ROE of +0.00%. Regarding short-term risk, ISCO is more volatile compared to VSBC. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, FGHQF has a market cap of 205.6M. Regarding current trading prices, ISCO is priced at $0.17, while FGHQF trades at $0.10.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas FGHQF's P/E ratio is 10.10. In terms of profitability, ISCO's ROE is +0.32%, compared to FGHQF's ROE of +0.00%. Regarding short-term risk, ISCO is less volatile compared to FGHQF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, SPHDF has a market cap of 204.7M. Regarding current trading prices, ISCO is priced at $0.17, while SPHDF trades at $15.90.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas SPHDF's P/E ratio is -3.93. In terms of profitability, ISCO's ROE is +0.32%, compared to SPHDF's ROE of +0.89%. Regarding short-term risk, ISCO is less volatile compared to SPHDF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, HNSBF has a market cap of 203.4M. Regarding current trading prices, ISCO is priced at $0.17, while HNSBF trades at $3.00.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas HNSBF's P/E ratio is -2.34. In terms of profitability, ISCO's ROE is +0.32%, compared to HNSBF's ROE of +1.43%. Regarding short-term risk, ISCO is more volatile compared to HNSBF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, BSEM has a market cap of 187.9M. Regarding current trading prices, ISCO is priced at $0.17, while BSEM trades at $11.50.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas BSEM's P/E ratio is -20.18. In terms of profitability, ISCO's ROE is +0.32%, compared to BSEM's ROE of +1.50%. Regarding short-term risk, ISCO is more volatile compared to BSEM. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, GNFTF has a market cap of 176.3M. Regarding current trading prices, ISCO is priced at $0.17, while GNFTF trades at $3.54.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas GNFTF's P/E ratio is 8.85. In terms of profitability, ISCO's ROE is +0.32%, compared to GNFTF's ROE of +0.27%. Regarding short-term risk, ISCO is less volatile compared to GNFTF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, SCNLF has a market cap of 176M. Regarding current trading prices, ISCO is priced at $0.17, while SCNLF trades at $0.17.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas SCNLF's P/E ratio is -5.66. In terms of profitability, ISCO's ROE is +0.32%, compared to SCNLF's ROE of +2.45%. Regarding short-term risk, ISCO is more volatile compared to SCNLF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, OPORF has a market cap of 164.9M. Regarding current trading prices, ISCO is priced at $0.17, while OPORF trades at $0.24.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas OPORF's P/E ratio is 12.00. In terms of profitability, ISCO's ROE is +0.32%, compared to OPORF's ROE of +0.42%. Regarding short-term risk, ISCO is less volatile compared to OPORF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, RECEF has a market cap of 157.2M. Regarding current trading prices, ISCO is priced at $0.17, while RECEF trades at $0.60.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas RECEF's P/E ratio is -10.00. In terms of profitability, ISCO's ROE is +0.32%, compared to RECEF's ROE of +2.26%. Regarding short-term risk, ISCO is less volatile compared to RECEF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, MLLCF has a market cap of 155.6M. Regarding current trading prices, ISCO is priced at $0.17, while MLLCF trades at $4.22.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas MLLCF's P/E ratio is -2.05. In terms of profitability, ISCO's ROE is +0.32%, compared to MLLCF's ROE of -0.36%. Regarding short-term risk, ISCO is more volatile compared to MLLCF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, AVCTF has a market cap of 153.8M. Regarding current trading prices, ISCO is priced at $0.17, while AVCTF trades at $0.40.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas AVCTF's P/E ratio is -3.34. In terms of profitability, ISCO's ROE is +0.32%, compared to AVCTF's ROE of -1.24%. Regarding short-term risk, ISCO is less volatile compared to AVCTF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, SLNCF has a market cap of 137.4M. Regarding current trading prices, ISCO is priced at $0.17, while SLNCF trades at $0.97.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas SLNCF's P/E ratio is -1.90. In terms of profitability, ISCO's ROE is +0.32%, compared to SLNCF's ROE of -0.87%. Regarding short-term risk, ISCO is less volatile compared to SLNCF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, BRIBF has a market cap of 134.1M. Regarding current trading prices, ISCO is priced at $0.17, while BRIBF trades at $0.18.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas BRIBF's P/E ratio is -1.83. In terms of profitability, ISCO's ROE is +0.32%, compared to BRIBF's ROE of -0.10%. Regarding short-term risk, ISCO is more volatile compared to BRIBF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, IPHYF has a market cap of 133.6M. Regarding current trading prices, ISCO is priced at $0.17, while IPHYF trades at $1.45.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas IPHYF's P/E ratio is -2.10. In terms of profitability, ISCO's ROE is +0.32%, compared to IPHYF's ROE of -1.81%. Regarding short-term risk, ISCO is less volatile compared to IPHYF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, AAPGV has a market cap of 127.3M. Regarding current trading prices, ISCO is priced at $0.17, while AAPGV trades at $17.38.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas AAPGV's P/E ratio is N/A. In terms of profitability, ISCO's ROE is +0.32%, compared to AAPGV's ROE of N/A. Regarding short-term risk, ISCO is less volatile compared to AAPGV. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, IUGNF has a market cap of 126.9M. Regarding current trading prices, ISCO is priced at $0.17, while IUGNF trades at $0.02.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas IUGNF's P/E ratio is -1.70. In terms of profitability, ISCO's ROE is +0.32%, compared to IUGNF's ROE of -0.96%. Regarding short-term risk, ISCO is less volatile compared to IUGNF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, PRNAF has a market cap of 126.9M. Regarding current trading prices, ISCO is priced at $0.17, while PRNAF trades at $0.01.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas PRNAF's P/E ratio is -1.39. In terms of profitability, ISCO's ROE is +0.32%, compared to PRNAF's ROE of -1.77%. Regarding short-term risk, ISCO is more volatile compared to PRNAF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, AMGXF has a market cap of 121.8M. Regarding current trading prices, ISCO is priced at $0.17, while AMGXF trades at $0.36.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas AMGXF's P/E ratio is -0.46. In terms of profitability, ISCO's ROE is +0.32%, compared to AMGXF's ROE of -0.24%. Regarding short-term risk, ISCO is less volatile compared to AMGXF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, PSTTF has a market cap of 117.5M. Regarding current trading prices, ISCO is priced at $0.17, while PSTTF trades at $0.15.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas PSTTF's P/E ratio is -29.00. In terms of profitability, ISCO's ROE is +0.32%, compared to PSTTF's ROE of N/A. Regarding short-term risk, ISCO is more volatile compared to PSTTF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, EPRXF has a market cap of 108.3M. Regarding current trading prices, ISCO is priced at $0.17, while EPRXF trades at $3.04.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas EPRXF's P/E ratio is -2.69. In terms of profitability, ISCO's ROE is +0.32%, compared to EPRXF's ROE of -1.99%. Regarding short-term risk, ISCO is less volatile compared to EPRXF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, ADOIF has a market cap of 103.7M. Regarding current trading prices, ISCO is priced at $0.17, while ADOIF trades at $8.87.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas ADOIF's P/E ratio is -2.59. In terms of profitability, ISCO's ROE is +0.32%, compared to ADOIF's ROE of +6.08%. Regarding short-term risk, ISCO is more volatile compared to ADOIF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, PBIGF has a market cap of 100M. Regarding current trading prices, ISCO is priced at $0.17, while PBIGF trades at $0.26.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas PBIGF's P/E ratio is -8.56. In terms of profitability, ISCO's ROE is +0.32%, compared to PBIGF's ROE of -2.16%. Regarding short-term risk, ISCO is less volatile compared to PBIGF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, TRGNF has a market cap of 92.4M. Regarding current trading prices, ISCO is priced at $0.17, while TRGNF trades at $0.70.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas TRGNF's P/E ratio is -2.12. In terms of profitability, ISCO's ROE is +0.32%, compared to TRGNF's ROE of -3.14%. Regarding short-term risk, ISCO is less volatile compared to TRGNF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, CMVLF has a market cap of 90.1M. Regarding current trading prices, ISCO is priced at $0.17, while CMVLF trades at $1.25.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas CMVLF's P/E ratio is -1.87. In terms of profitability, ISCO's ROE is +0.32%, compared to CMVLF's ROE of -0.30%. Regarding short-term risk, ISCO is less volatile compared to CMVLF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, ACHFF has a market cap of 87M. Regarding current trading prices, ISCO is priced at $0.17, while ACHFF trades at $1.32.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas ACHFF's P/E ratio is -33.00. In terms of profitability, ISCO's ROE is +0.32%, compared to ACHFF's ROE of +0.56%. Regarding short-term risk, ISCO is more volatile compared to ACHFF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, MCURF has a market cap of 86.5M. Regarding current trading prices, ISCO is priced at $0.17, while MCURF trades at $0.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas MCURF's P/E ratio is -16.90. In terms of profitability, ISCO's ROE is +0.32%, compared to MCURF's ROE of -1.02%. Regarding short-term risk, ISCO is less volatile compared to MCURF. This indicates potentially lower risk in terms of short-term price fluctuations for ISCO.

ISCO plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, ISCO stands at 1.3M. In comparison, MSCLF has a market cap of 84.6M. Regarding current trading prices, ISCO is priced at $0.17, while MSCLF trades at $0.51.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

ISCO currently has a P/E ratio of -5.56, whereas MSCLF's P/E ratio is 3.00. In terms of profitability, ISCO's ROE is +0.32%, compared to MSCLF's ROE of -0.74%. Regarding short-term risk, ISCO is more volatile compared to MSCLF. This indicates potentially higher risk in terms of short-term price fluctuations for ISCO.